Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects. (Record no. 23800288)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01891 a2200505 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250516212024.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201409s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 0946-1965 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.5414/CP202091 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | De Kam, Pieter-Jan |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20140925 |
| 245 00 - TITLE STATEMENT | |
| Title | Lack of a clinically relevant effect of sugammadex on anti-Xa activity or activated partial thromboplastin time following pretreatment with either unfractionated or low-molecular-weight heparin in healthy subjects. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | International journal of clinical pharmacology and therapeutics |
| Date of publication, distribution, etc. | Aug 2014 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 631-41 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Anticoagulants |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Cross-Over Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Double-Blind Method |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Interactions |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Enoxaparin |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Factor Xa Inhibitors |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Heparin |
| General subdivision | pharmacology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Partial Thromboplastin Time |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sugammadex |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | gamma-Cyclodextrins |
| General subdivision | administration & dosage |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kruithof, Annelieke C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Lierop, Marie-José |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Moerland, Matthijs |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dennie, Justin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Troyer, Matthew D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Langdon, Ronald B |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gutstein, David E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Burggraaf, Jacobus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | El Galta, Rachid |
| 773 0# - HOST ITEM ENTRY | |
| Title | International journal of clinical pharmacology and therapeutics |
| Related parts | vol. 52 |
| -- | no. 8 |
| -- | p. 631-41 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.5414/CP202091">https://doi.org/10.5414/CP202091</a> |
| Public note | Available from publisher's website |
No items available.